ASHP Psychiatric Pharmacy Review Helps Practitioner Prepare for BPS Exam
Pharmacy practitioners preparing for the 2001 Board of Pharmaceutical Specialties (BPS) certification examination in psychiatric pharmacy can again take advantage of a review course from the American Society of Health-System Pharmacists (ASHP). Thanks to funding from Janssen Pharmaceutica, the course will be offered March 31- April 1, 2001 in Denver. The course will also be available on the ASHP Web site, www.ashp.org.
During the two-day live course, attendees will receive a concentrated update on disease states and therapies, pharmacology, and statistics related to psychiatric pharmacy. The course is not intended to be an introduction to these concepts, but will help experienced psychiatric pharmacy practitioners recognize and address knowledge gaps. The curriculum, which is based on case studies, includes an extensive reference list of helpful resources. Participants will receive 17 hours of continuing education credit after completing the course.
The Web version of the course will follow the same outline and will allow practitioners to set their own study schedule. Participants will hear an audio presentation and view accompanying slides for up to 14 course modules and will be available in July 2001.
"ASHP strongly supports the efforts of practitioners who want to increase their knowledge and skills in order to strengthen their ability to care for patients," said ASHP President Mick L. Hunt, M.S., FASHP. "The online and live versions of the psychiatric pharmacy review course are excellent tools for those who are striving for national certification in their specialty."
The course, developed with the assistance of ASHP's Section of Clinical Specialists who served as content experts, has received rave reviews from previous participants. ASHP members worked closely with an instructional designer to develop a curricular-based program addressing content areas covered in the BPS examination.
"Mental-health consumers and the mental health care delivery team greatly benefit from access to pharmacists with special expertise in psychiatric medicine," said Ramy Mahmoud, MD, MPH, leader of psychiatry and neurology medical affairs for Janssen Pharmaceutica. "As a company with long history of discovery and development of drugs to improve mental health, and as marketers of the leading antipsychotic medication in the United States, Janssen is committed to sponsoring programs such as this to develop leaders in the field and improve patient care."
Enrollment is limited to 100 participants. Registration materials are available via ASHP's Web site, www.ashp.org, and by calling ASHP Customer Service at (301) 657-4383. The fee for the session is $200 for ASHP members and $260 for nonmembers if registered by the February 15, 2001 deadline.
ASHP is the 30,000-member national professional association that represents pharmacists who practice in hospitals, health maintenance organizations, long-term care facilities, home care, and other components of health care systems. ASHP believes that the mission of pharmacists is to help people make the best use of medications. Assisting pharmacists in fulfilling this mission is ASHP's primary objective. The Society has extensive publishing and educational programs designed to help members improve their delivery of pharmaceutical care, and it is the national accrediting organization for pharmacy residency and pharmacy technician training programs.